Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Merck Serono Opens Beijing Lab

publication date: Sep 1, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Merck Serono, the biopharmaceutical division of Merck KGaA, has opened a China lab as part of its planned R&D hub in Beijing. The lab, which has $5.8 million of equipment, will pursue individualized treatments for cancer, neural degenerative disease and autoimmune and inflammatory disorders. More details....

Stock Symbol: (Xetra: MRK)     Share this with colleagues:  

 




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors